VIZO-PF DORZOLATIM (AFT Pharmaceuticals Pty Ltd)
Product name
VIZO-PF DORZOLATIM
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
139 (255 working days)
Active ingredients
dorzolamide hydrochloride; timolol maleate
Registration type
New generic medicine
Indication
VIZO-PF DORZOLATIM (eye drop solution) is indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.